Literature DB >> 11606376

Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype.

H Seker1, D Butkiewicz, E D Bowman, M Rusin, M Hedayati, L Grossman, C C Harris.   

Abstract

Recent molecular epidemiological studies have identified polymorphisms in the XPD gene that are associated with increased risk of brain gliomas and head, neck, lung, and skin cancers. However, the functional significance of these polymorphic variants in altering cell processes such as cell cycle checkpoints, DNA repair, and apoptosis is uncertain. We have cloned the XPD variants Lys751Gln, Asp312Asn, and Lys751Gln-Asp312Asn into a pcDNA-3.1-expression vector. Using these constructs, we did not find any detectable difference in either in vitro binding with wild-type p53 or in DNA repair proficiency as measured by host cell reactivation assay. We then genotyped 34 different lymphoblastoid cell lines from six Centre d'Etude du Polymorphisme Humaine (CEPH)/Utah pedigree families and a CEPH/French pedigree family for polymorphisms at codons 751 and 312 and assessed their apoptotic response after either UV or ionized radiation exposure. The lymphoblastoid cell lines with homozygous or heterozygous Asp at codon 312 have similar apoptotic rates, whereas cell lines with homozygous Asn at codon 312 showed a 2.5-fold increased response to UV (P = 0.005; Student's t test). This is the first report known to us of a functional polymorphism in a gene involved in DNA damage-induced apoptosis. However, the presence of Lys or Gln at codon 751 did not influence the apoptotic response to UV. The diminished apoptotic response of cells containing the 312 Asp allele could both allow the survival and selective clonal expansion of carcinogen-damaged cells and be a mechanistic explanation for the increased risk of cancer at diverse tissue sites.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606376

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk.

Authors:  Li Jiao; Manal M Hassan; Melissa L Bondy; James L Abbruzzese; Douglas B Evans; Donghui Li
Journal:  Cancer Lett       Date:  2006-02-03       Impact factor: 8.679

2.  Nucleotide excision repair gene polymorphisms, meat intake and colon cancer risk.

Authors:  Susan E Steck; Lesley M Butler; Temitope Keku; Samuel Antwi; Joseph Galanko; Robert S Sandler; Jennifer J Hu
Journal:  Mutat Res       Date:  2014-03-07       Impact factor: 2.433

Review 3.  Polymorphisms in DNA damage response genes and head and neck cancer risk.

Authors:  Rafael E Flores-Obando; Susanne M Gollin; Camille C Ragin
Journal:  Biomarkers       Date:  2010-08       Impact factor: 2.658

4.  Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions.

Authors:  Kathleen M McCarty; Thomas J Smith; Wei Zhou; Ernesto Gonzalez; Quazzi Quamruzzaman; Mahmuder Rahman; Golam Mahiuddin; Louise Ryan; Li Su; David C Christiani
Journal:  Carcinogenesis       Date:  2007-04-29       Impact factor: 4.944

5.  The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck.

Authors:  Chunying Li; Jiachun Lu; Zhensheng Liu; Li-E Wang; Hui Zhao; Adel K El-Naggar; Erich M Sturgis; Qingyi Wei
Journal:  Cancer Prev Res (Phila)       Date:  2010-01-19

6.  Contribution of XPD (Lys751Gln) and XRCC1 (Arg399Gln) polymorphisms in familial and sporadic breast cancer predisposition and survival: an Indian report.

Authors:  Volga S Syamala; Vani Syamala; Hariharan Sreedharan; Praveenkumar B Raveendran; Ratheesan Kuttan; Ravindran Ankathil
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

7.  Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.

Authors:  Mariana C Stern; Jie Lin; Jonine D Figueroa; Karl T Kelsey; Anne E Kiltie; Jian-Min Yuan; Giuseppe Matullo; Tony Fletcher; Simone Benhamou; Jack A Taylor; Donatella Placidi; Zuo-Feng Zhang; Gunnar Steineck; Nathaniel Rothman; Manolis Kogevinas; Debra Silverman; Nuria Malats; Stephen Chanock; Xifeng Wu; Margaret R Karagas; Angeline S Andrew; Heather H Nelson; D Timothy Bishop; Sei Chung Sak; Ananya Choudhury; Jennifer H Barrett; Faye Elliot; Román Corral; Amit D Joshi; Manuela Gago-Dominguez; Victoria K Cortessis; Yong-Bing Xiang; Yu-Tang Gao; Paolo Vineis; Carlotta Sacerdote; Simonetta Guarrera; Silvia Polidoro; Alessandra Allione; Eugen Gurzau; Kvetoslava Koppova; Rajiv Kumar; Peter Rudnai; Stefano Porru; Angela Carta; Marcello Campagna; Cecilia Arici; Sung Shim Lani Park; Montserrat Garcia-Closas
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

8.  Genetic polymorphisms in RAD23B and XPC modulate DNA repair capacity and breast cancer risk in Puerto Rican women.

Authors:  Julyann Pérez-Mayoral; Alba L Pacheco-Torres; Luisa Morales; Heidi Acosta-Rodríguez; Jaime L Matta; Julie Dutil
Journal:  Mol Carcinog       Date:  2013-06-18       Impact factor: 4.784

Review 9.  Cancer pharmacogenomics: role of DNA repair genetic polymorphisms in individualizing cancer therapy.

Authors:  Lucy Gossage; Srinivasan Madhusudan
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

10.  Statistically significant association of the single nucleotide polymorphism (SNP) rs13181 (ERCC2) with predisposition to Squamous Cell Carcinomas of the Head and Neck (SCCHN) and Breast cancer in the north Indian population.

Authors:  Amit Kumar Mitra; Neetu Singh; Vivek Kumar Garg; Rashmi Chaturvedi; Mandira Sharma; Srikanta Kumar Rath
Journal:  J Exp Clin Cancer Res       Date:  2009-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.